Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
Neurotoxicity and physicochemical properties of Abeta mutant peptides from cerebral amyloid angiopathy: implication for the pathogenesis of cerebral amyloid angiopathy and Alzheimer's disease.
[hereditary cerebral hemorrhage with amyloidosis]
Cerebral
amyloid
angiopathy
(
CAA
)
due
to
beta
-amyloid
(
Abeta
)
is
one
of
the
specific
pathological
features
of
familial
Alzheimer
's
disease
.
Abeta
mainly
consisting
of
40
-
and
42
-
mer
peptides
(
Abeta
40
and
Abeta
42
)
exhibits
neurotoxicity
and
aggregative
abilities
.
All
of
the
variants
of
Abeta
40
and
Abeta
42
found
in
CAA
were
synthesized
in
a
highly
pure
form
and
examined
for
neurotoxicity
in
PC
12
cells
and
aggregative
ability
.
All
of
the
Abeta
40
mutants
at
positions
22
and
23
showed
stronger
neurotoxicity
than
wild-
type
Abeta
40
.
Similar
tendency
was
observed
for
Abeta
42
mutants
at
positions
22
and
23
whose
neurotoxicity
was
50
-
200
times
stronger
than
that
of
the
corresponding
Abeta
40
mutants
,
suggesting
that
these
Abeta
42
mutants
are
mainly
involved
in
the
pathogenesis
of
CAA
.
Although
the
aggregation
of
E
22
G
-Abeta
42
and
D
23
N
-Abeta
42
was
similar
to
that
of
wild-
type
Abeta
42
,
E
22
Q-Abeta
42
and
E
22
K
-Abeta
42
aggregated
extensively
,
supporting
the
clinical
evidence
that
Dutch
and
Italian
patients
are
diagnosed
as
hereditary
cerebral
hemorrhage
with
amyloidosis
.
In
contrast
,
A
21
G
mutation
needs
alternative
explanation
with
the
exception
of
physicochemical
properties
of
Abeta
mutants
.
Attenuated
total
reflection-
Fourier
transform
infrared
spectroscopy
spectra
suggested
that
beta
-sheet
content
of
the
Abeta
mutants
correlates
with
their
aggregation
.
However
,
beta
-turn
is
also
a
critical
secondary
structure
because
residues
at
positions
22
and
23
that
preferably
form
two
-residue
beta
-turn
significantly
enhanced
the
aggregative
ability
.
Diseases
Validation
Diseases presenting
"specific pathological features"
symptom
hereditary cerebral hemorrhage with amyloidosis
You can validate or delete this automatically detected symptom
Validate the Symptom
Delete the Symptom